Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 8/20 | 0.66 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.53 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.53 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.47 |
| ▸ | NAAA | Q02083 | 1/20 | 0.44 |
| ▸ | FAAH | O00519 | 1/20 | 0.44 |
| ▸ | PSMD14 | O00487 | 2/20 | 0.43 |
| ▸ | PLA2G1B | P04054 | 2/20 | 0.43 |
| ▸ | MMP2 | P08253 | 2/20 | 0.43 |
| ▸ | ATG4B | Q9Y4P1 | 2/20 | 0.43 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | RAD52 | P43351 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16280550 | 1.00 | GPR84 (0.66) | GPR84FFAR1FFAR4NFKB1NAAA | |
| SCHEMBL28211118 | 0.93 | GPR84 (0.58) | GPR84FFAR1FFAR4NFKB1FAAH | |
| SCHEMBL28211041 | 0.93 | GPR84 (0.58) | GPR84FFAR1FFAR4NFKB1FAAH | |
| SCHEMBL29171100 | 0.93 | GPR84 (0.58) | GPR84FFAR1FFAR4NFKB1FAAH | |
| SCHEMBL27562782 | 0.93 | GPR84 (0.58) | GPR84FFAR1FFAR4NFKB1FAAH | |
| SCHEMBL27603022 | 0.91 | GPR84 (0.55) | GPR84FFAR1FFAR4NFKB1PSMD14 | |
| SCHEMBL27691245 | 0.87 | GPR84 (0.51) | GPR84FFAR1FFAR4FAAHKDM4E | |
| SCHEMBL4257991 | 0.87 | GPR84 (0.51) | GPR84FFAR1FFAR4FAAHPSMD14 | |
| SCHEMBL8413382 | 0.86 | GPR84 (0.63) | GPR84FFAR1FFAR4NFKB1FAAH | |
| SCHEMBL7599878 | 0.86 | GPR84 (0.63) | GPR84FFAR1FFAR4NFKB1FAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4330418-A1 | PROCESS TO PRODUCE MONO-RHAMNOLIPIDS | Unilever IP Holdings B.V. (NL) | 2024-03-06 | — | — | EP | disclosed |
| EP-4330362-A1 | PROCESS TO PRODUCE MONO-RHAMNOLIPIDS | Unilever IP Holdings B.V. (NL) | 2024-03-06 | — | — | EP | disclosed |
| WO-2022229069-A1 | PROCESS TO PRODUCE MONO-RHAMNOLIPIDS | UNILEVER IP HOLDINGS B.V. (NL) | 2022-11-03 | — | — | WO | disclosed |
| WO-2022229052-A1 | PROCESS TO PRODUCE MONO-RHAMNOLIPIDS | UNILEVER IP HOLDINGS B.V. (NL) | 2022-11-03 | — | — | WO | disclosed |
| CN-108060111-B | Pseudomonas aeruginosa for increasing rhamnolipid yield and construction method thereof | 中国科学院微生物研究所 | 2021-06-04 | — | — | CN | disclosed |
| US-10190144-B2 | Production of dirhamnose-lipid in recombinant nonpathogenic bacterium Pseudomonas chlororaphis | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF AGRICULTURE (US) | 2019-01-29 | — | — | US | disclosed |
| CN-108587989-A | A kind of bacterial strain and production method for producing 3- hydroxydecanoic acids | 中国科学院微生物研究所 | 2018-09-28 | — | — | CN | disclosed |
| CN-106414758-A | Method for producing rhamnolipid | 赢创德固赛有限公司 | 2017-02-15 | — | — | CN | disclosed |
| US-20160102330-A1 | PRODUCTION OF DIRHAMNOSE-LIPID IN RECOMBINANT NONPATHOGENIC BACTERIUM PSEUDOMONAS CHLORORAPHIS | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF AGRICULTURE | 2016-04-14 | — | — | US | disclosed |
| CN-104762313-A | Rhamnolipid yield increasing genetic engineering method and special strain | CHINESE ACAD INST MICROBIOLOGY | 2015-07-08 | — | — | CN | disclosed |
| WO-2014197457-A1 | PRODUCTION OF DIRHAMNOSE-LIPID IN RECOMBINANT NONPATHOGENIC BACTERIUM PSEUDOMONAS CHLORORAPHIS | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF AGRICULTURE (US) | 2014-12-11 | — | — | WO | disclosed |
| CN-104099388-A | Method for increasing yield of rhamnolipid and special pseudomonas aeruginosa for preparing rhamnolipid | CHINESE ACAD INST MICROBIOLOGY | 2014-10-15 | — | — | CN | disclosed |
| EP-0920517-B1 | DNA SEQUENCE USEFUL FOR THE PRODUCTION OF POLYHYDROXYALKANOATES | METABOLIX INC (US) | 2010-11-10 | — | — | EP | disclosed |
| US-20060150279-A1 | Bioremediation with transgenic plants | PLANT BIOSCIENCE LIMITED (GB) | 2006-07-06 | — | — | US | disclosed |
| EP-1567649-A1 | BIOREMEDIATION WITH TRANSGENIC PLANTS | Plant Bioscience Limited (GB) | 2005-08-31 | — | — | EP | disclosed |
| WO-2004050882-A1 | BIOREMEDIATION WITH TRANSGENIC PLANTS | PLANT BIOSCIENCE LIMITED (GB) | 2004-06-17 | — | — | WO | disclosed |
| US-RE37543-E1 | CLONED BY PHENOTYPE COMPLEMENTATION OF PSEUDOMONAS PUTIDA KT2440 MUTANTS, DEFECTIVE IN THE POLYHYDROXYALKANOIC ACID (PHA) SYNTHESIS VIA DE NOVO FATTY ACID BIOSYNTHESIS BUT NOT AFFECTED IN PHA BIOSYNTHESIS VIA FATTY ACID B-OXIDATION | MONSANTO COMPANY | 2002-02-05 | — | — | US | disclosed |
| EP-0920517-A1 | DNA SEQUENCE USEFUL FOR THE PRODUCTION OF POLYHYDROXYALKANOATES | MONSANTO COMPANY (US) | 1999-06-09 | — | — | EP | disclosed |
| US-5750848-A | DNA sequence useful for the production of polyhydroxyalkanoates | MONSANTO COMPANY (US) | 1998-05-12 | — | — | US | disclosed |
| WO-1998006854-A1 | DNA SEQUENCE USEFUL FOR THE PRODUCTION OF POLYHYDROXYALKANOATES | MONSANTO COMPANY (US) | 1998-02-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10190144-B2 | Production of dirhamnose-lipid in recombinant nonpathogenic bacterium Pseudomonas chlororaphis | MRPL21, DAGLA, MGLL | GPR84 1913/4885FFAR1 291/4885FFAR4 539/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.